InvestorsHub Logo
Followers 58
Posts 10319
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 212083

Sunday, 09/29/2019 11:32:05 AM

Sunday, September 29, 2019 11:32:05 AM

Post# of 469988

we don't want to know because it could hurt sales" stuff?



There is a classic dilemma that needs to be addressed. I do not want to pick on regulatory bodies but, it is what it is.

If a regulatory body is held responsible to reduce/manage/control risk and if they get real good at it then what are the rest of us supposed to do? Sit and watch while nothing happens.

When controls are so good and penalties are so high the incentive to take new product risk is gone/prevented...etc. It stops. So, we have idiotic attempts like the entire Amyloid thesis model that go one and on. rules then get built around how to do that by massive trials w/statistical models that only suite the zero risk crowd. No wonder we stayed in the same place for decades when a child could see it was a dry hole w/o clear causation proof. These clusters looked bad, they MUST BE the cause. anyone not buying in got hammered by BP who were the only ones rich enough to play the games. In the meantime, FDA was smart enough to see who was paying the bills and sang the same song. That is not science, that is crowd management 101.

So, getting the right balance of progress and risk is the problem. When constrained by lack of knowledge no progress is made. IMO, AVXL presents a massive threat to the current systems of thinking who are hanging on to the YAA BUT RISK model.

So, managing risk in CNS disease is being taken off the table by Dr.M and team w/CNS Cellular Homeostasis as a step in the right direction. Maybe just the first step but it is a big one. I am not saying the entire BP/who knows systemic wall is against AVXL but they are the ones who stand to lose the most from the looks of it.

IMO then RTT and somehow getting past the RISK BOOGEY MAN is key. I do think also that some RSD Mom will kick their ass. That is what I am looking for.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News